Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection
7 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides nucleoside cyclic phosphoramidates of formula (I), pharmaceutical compositions comprising the compounds of formula (I) and methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection using the compounds of formula (I).
-
Citations
17 Claims
- 1. A compound of the structural formula I:
Specification